文献速递慢性静脉疾病

下肢静脉曲张患者腔内射频消融与激光消融的比较:一项Meta分析

Endovenous radiofrequency ablation vs laser ablation in patients with lower extremity varicose veins: A meta-analysis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-02-03

该Meta分析纳入29项研究(16项随机对照试验和13项队列研究),比较射频消融(RFA)与激光消融(LA)治疗下肢静脉曲张的早期和长期结局。1个月和1年的大隐静脉(GSV)闭塞率两组相近;2016年以来RFA的1年GSV闭塞率更高(93.27% vs 91.24%;OR,1.35;95%CI,1.0-1.83;P=0.05)。RFA的烧伤和瘀斑、术后疼痛、静脉曲张复发及感觉异常风险较低,但皮肤色素沉着风险较高。

要点

  • RFA与LA在早期和长期GSV闭塞率及血栓、静脉炎并发症方面疗效相似。
  • 2016年以来RFA的1年GSV闭塞率高于LA(93.27% vs 91.24%;OR,1.35;95%CI,1.0-1.83;P=0.05)。
  • RFA的烧伤和瘀斑、术后疼痛、静脉曲张复发及感觉异常风险低于LA,但皮肤色素沉着风险高于LA。

核心结论

  • RFA与LA在早期和长期GSV闭塞率及血栓和静脉炎并发症发生率方面疗效相似;但2016年以来RFA的GSV闭塞率高于LA,且RFA的感觉异常、烧伤和瘀斑及静脉曲张复发并发症较少。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase和Cochrane数据库截至2023年6月,纳入29项研究(16项随机对照试验和13项队列研究),比较RFA与LA治疗原发性下肢静脉曲张。

主要发现

  • 1个月GSV闭塞率RFA为98.35%,LA为98.04%;1年GSV闭塞率RFA为93.13%,LA为94.18%。
  • 2016年以来1年GSV闭塞率RFA为93.27% vs LA为91.24%(OR,1.35;95%CI,1.0-1.83;P=0.05)。
  • 1个月术后静脉血栓事件发生率RFA为0.78%,LA为0.87%(OR,1.46;95%CI,0.77-2.74;P=0.24)。
  • RFA较LA降低烧伤和瘀斑风险(OR,0.65;95%CI,0.48-0.87;P=0.005)、术后疼痛(均数差,-0.85;95%CI,-1.06至-0.64;P<0.001)、静脉曲张复发(OR,0.58;95%CI,0.36-0.92;P=0.02)及2016年以来感觉异常(OR,0.42;95%CI,0.19-0.91;P=0.03),但增加皮肤色素沉着风险(OR,1.75;95%CI,1.06-2.9;P=0.03)。
  • 静脉炎发生率RFA与LA相似(OR,0.87;95%CI,0.33-2.27;P=0.78)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovenous radiofrequency ablation (RFA) and laser ablation (LA) have been commonly used for treating lower extremity varicose veins (LEVVs). Their therapeutic effects have been widely recognized compared with conventional surgery. However, there have been some controversies regarding the choice between RFA and LA. The objective of our study was to conduct a systematic review and meta-analysis comparing the early and long-term outcomes of RFA and LA. METHODS: A comprehensive search was performed in the PubMed, Embase, and Cochrane databases to identify relevant literature on endovenous thermal ablation for primary LEVV up until June 2023. Randomized controlled trials, cohort studies, and case-control studies involving RFA and LA for LEVV treatment were included. The primary endpoints were the occlusion rate of the great saphenous vein (GSV) and occurrence of venous thrombotic events. Secondary outcomes included nerve injury, hyperpigmentation, burns, recurrence of VVs, postoperative pain, and phlebitis. Data were analyzed using Review Manager 5.3 software. RESULTS: A total of 29 studies met the inclusion criteria, consisting of 16 randomized controlled trials and 13 cohort studies. At 1 month, the occlusion rates of GSV were 98.35% for RFA and 98.04% for LA, whereas at 1 year, the rates were 93.13% for RFA and 94.18% for LA. Subgroup analyses revealed that RFA had higher GSV occlusion rates at 1 year since 2016 (93.27% vs 91.24%; odds ratio [OR], 1.35; 95% confidence interval [CI], 1.0-1.83; P = .05). The incidence of postoperative venous thrombotic events was 0.78% for RFA and 0.87% for LA at 1 month (OR, 1.46; 95% CI, 0.77-2.74; P = .24). RFA showed a reduced risk of burns and ecchymosis (OR, 0.65; 95% CI, 0.48-0.87; P = .005), postprocedural pain (mean difference, -0.85; 95% CI, -1.06 to -0.64; P < .001), recurrence of VVs (OR, 0.58; 95% CI, 0.36-0.92; P = .02), and paresthesia since 2016 (OR, 0.42; 95% CI, 0.19-0.91; P = .03), but an increased risk of skin pigmentation (OR, 1.75; 95% CI, 1.06-2.9; P = .03) compared with LA therapy. The rate of phlebitis was similar between RFA and LA (OR, 0.87; 95% CI, 0.33-2.27; P = .78). CONCLUSIONS: RFA and LA demonstrated similar efficacy in terms of early and long-term occlusion rates of GSV and the incidence of thrombotic and phlebitis complications. However, since 2016, RFA has shown higher GSV occlusion rates compared with LA. Furthermore, RFA was associated with fewer complications such as paresthesia, burns and ecchymosis, and recurrence of VVs when compared with LA.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Jiang W, Liang Y, Long Z, et al. Endovenous radiofrequency ablation vs laser ablation in patients with lower extremity varicose veins: A meta-analysis. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38316290. doi:10.1016/j.jvsv.2024.101842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。